Aurora Cannabis Inc. (Aurora) focuses on the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
The company’s primary market opportunities are:
Global medical cannabis market: Production, distribution and sale of pharmaceutical-grade cannabis products in countries around the world permitted by government legislation. There are approximately 50 countries that have implemented regimes for some form of access to cannabis for medical purp...
Aurora Cannabis Inc. (Aurora) focuses on the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
The company’s primary market opportunities are:
Global medical cannabis market: Production, distribution and sale of pharmaceutical-grade cannabis products in countries around the world permitted by government legislation. There are approximately 50 countries that have implemented regimes for some form of access to cannabis for medical purposes. The company’s principal medical markets are in Canada, Germany, the U.K., Poland, and Australia. Aurora has established a leading market position in most of these countries.
Global consumer use cannabis market: Canada and Uruguay have implemented federally regulated consumer use of cannabis regimes, and the company has primarily focused on the opportunities in Canada.
Strategy
Aurora’s strategy is to leverage its diversified and scaled platform, its leadership in global medical markets, and its cultivation, science and genetics expertise and capabilities to drive profitability in its core Canadian and international operations in order to build sustainable, long- term shareholder value.
The key elements of the company’s strategy include medical leadership; consumer; science leadership - Genetics, Breeding, and Biosynthetics; global and U.S. Expansion; and plant propagation.
Brands and Cannabis Products
Aurora’s principal market is patients and consumers who use cannabis in Canada and other international jurisdictions. The company is authorized to cultivate and sell dried cannabis, cannabis oils, capsules, edible cannabis and cannabis extracts pursuant to the requirements of the Cannabis Act. The company’s cannabis products can be ingested in a variety of ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts.
Medical
The company is paving the way to a new era of high-quality, consistent and innovative cannabis products. Its trusted family of medical brands showcase an extensive portfolio of products and delivery methods, offering unique, and research-based healthcare solutions.
As one of the first brands in the Canadian medical cannabis market, Aurora offers a wide range of cannabis products, including oils, capsules, dried flower, and vapes. As a longstanding supporter of Canadian veterans, Aurora drives veteran access to medical cannabis through strong prescriber/clinic relationships, robust veteran support programs, and ongoing advocacy work
The CanniMed Therapeutics Inc. (CanniMed) brand portfolio includes a number of dried milled strains and cannabis oils for medical patients. CanniMed’s 1:20 Oil has been used in clinical trials studying symptom management in treatment-resistant childhood epilepsies.
MedReleaf Corp. (MedReleaf) is known for its extensive product line and strain-specific extracts. MedReleaf products are safe and dependable medical cannabis that focus on individual patient needs to improve lives. The MedReleaf brand portfolio includes dried cannabis varieties, strain specific cannabis oils, capsules, vapes, and concentrates.
Founded in 2013, Whistler Medical Marijuana Inc. (WMMC) was the first Canadian Licensed Producer to obtain organic certification and sell a full suite of organic-certified cannabis products. WMMC has commercialized more than 30 flower varieties and strain-specific oil products from an extensive genetics bank of over 150 strains.
One of the leading medical cannabis brands in the German market, Pedanios offers flower, and full spectrum extracts to suit patient’s needs.
Bidiol is a brand of high-quality medical cannabis, made in a state-of-the-art extraction and formulation lab in Uruguay. Products are developed under strict quality controls, from the planting of hemp to the production and extraction of CBD to manufacture a superior quality medical product.
Consumer
The company provides a broad selection of high-quality recreational cannabis products in different formats. There’s something for everyone to enjoy with its flowers, vapes, ingestibles, concentrates, extracts, and CBD products.
Product Development
In fiscal 2024, the company launched over 140 new SKUs across all channels a number of new products, with a focus on delivering high quality experiences to patients and consumers across all major categories: flower, pre-rolls, oils, concentrates, vapes, and gummies. The company has a robust pipeline of new products for all categories, positioned to deliver for all channels and regions.
Patient Counseling and Outreach Services
Aurora provides patient counseling and outreach services through its subsidiary CanvasRx, as well as through a number of other cannabis clinics. CanvasRx helps patients learn how to safely and effectively use medical cannabis, how to select a strain from the hundreds available in Canada and how to register with their choice of Licensed Producer. CanvasRx plays an important role in supporting the medical cannabis segment domestically through the ongoing education of physicians and patients interested in learning more about the medical benefits of cannabis and the procedures under applicable regulations to obtain cannabis. CanvasRx increases Aurora’s presence in the medical cannabis sector and provides Aurora with access to valuable aggregate data on patient use of medical cannabis, the ability to jointly develop new services for patients, and the insight necessary to tailor its product line to offer an industry-leading and demand-matching selection of products and strains tailored to the needs of patients
Distribution Methods
The company distributes cannabis products in accordance with the various regulatory frameworks in the respective provinces and territories governing the medical and consumer cannabis markets in Canada. It also distributes medical cannabis products internationally in accordance with applicable international laws and regulations. The company has robust distribution networks spanning every province and territory in Canada in both the recreational and medical cannabis markets and are operating in other locations worldwide.
The company’s registered patients can order products directly from Aurora through its online shop or by phoning its client care center. Medical cannabis is, and will continue to be, delivered by secured courier or other methods permitted by the Cannabis Act.
Distribution of cannabis to the adult-use consumer market in Canada is done through provincial regulators. The company has agreements with provincial regulators to supply cannabis for the Canadian adult-use consumer market. Under the terms of these agreements, the company supplies the provinces with a wide variety of product from its various facilities. Supply quantities are determined based on demand on an ongoing basis.
Through a combination of strategic investments, domestic production, and supply agreements, it is positioned to access a growing number of key international markets. With the EU and TGA GMP and the Control Union Medical Cannabis Standard GACP certification (CUMCS) certifications of certain of its facilities, the company is one of only a handful of companies globally with this pharma-grade designation across both production and distribution facilities in Canada and Germany respectively, allowing it to sell into the most restrictive and promising markets in Europe and abroad.
Intangible Properties
The company owns trademark applications and registrations for its brands and product names in Canada and internationally, and have rights to 11 patent families filed globally, making up approximately 14 issued patents and/or patent pending applications in technical areas, including genetics; horticultural methods and apparatus; medical and recreational products; and plant variety protection.
History
Aurora Cannabis Inc. was founded in 2013.
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
